Charles River Laboratories (NYSE:CRL)
CAPS Rating:
The Company is a global provider of solutions that advance the drug discovery and development process. It provides the animal research models required in research and development for new drugs, devices and therapies.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
0
Recs
2
86Targa
(< 20)
Submitted: 3/23/2007 3:15:06 PM :
Start Price:
$46.02
CRL Score:
-24.39
CRL is divesting itself of divisions that do not fit the market niche they moving towards. Their deal to expand to China will do nothing more than improve their presence in the global market for pre-clinicals
Recs
3
indyjoneses
(99.52)
Submitted: 12/28/2006 7:13:34 PM :
Start Price:
$43.55
CRL Score:
-21.65
Given current trend in Pharma industry to outsource as opposed to hiring, I would expect companies like this that provide specialized and necessary services to Pharma to do well in the long run, regardless of what happens to the stock prices of the pharma sector.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 21 - 23 of 23 : « Previous 1 2